Omori Shigehiro, Kamiya Yusuke, Yamaki Tsutomu, Uchida Masaki, Ohtake Kazuo, Kimura Mitsutoshi, Natsume Hideshi
Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University.
Biol Pharm Bull. 2019;42(1):144-148. doi: 10.1248/bpb.b18-00673.
The transnasal route for the delivery of water-soluble macromolecules, such as bioactive peptides and proteins, has attracted interest, although the use of permeation enhancers is required due to the poor permeabilities of these macromolecules across the nasal mucosa. With polycationic compounds, such as poly-L-arginine and chitosan, the nasal absorption of hydrophilic macromolecules is molecular weight- and concentration-dependently enhanced without causing cytotoxicity. In the present study, we evaluated the effect of various molecular weights and concentrations of poly-L-ornithine (PLO), a polycationic compound, on the nasal absorption and the damage to the nasal mucosa in vivo. PLO enhanced the nasal absorption of fluorescein isothiocyanate-dextran (FD-4), used as a model drug, and the bioavailability of FD-4 increased with the concentration of PLO. The enhancement effect was also dependent on the molecular weight. The administration of PLO at a concentration that sufficed for enhancing the nasal absorption had no effect on the activity of lactic dehydrogenase and the protein leakage in the nasal fluid, as indices of nasal mucosa damage. These findings suggest that a transnasal delivery system using PLO is a useful strategy for improving the nasal absorption of water-soluble macromolecules without toxicity to the nasal mucosa.
用于递送水溶性大分子(如生物活性肽和蛋白质)的经鼻途径已引起关注,尽管由于这些大分子穿过鼻黏膜的渗透性较差而需要使用渗透促进剂。使用聚阳离子化合物(如聚-L-精氨酸和壳聚糖)时,亲水性大分子的鼻吸收会随分子量和浓度的增加而增强,且不会产生细胞毒性。在本研究中,我们评估了聚阳离子化合物聚-L-鸟氨酸(PLO)的不同分子量和浓度对体内鼻吸收及鼻黏膜损伤的影响。PLO增强了用作模型药物的异硫氰酸荧光素-葡聚糖(FD-4)的鼻吸收,且FD-4的生物利用度随PLO浓度的增加而提高。增强作用也取决于分子量。以足以增强鼻吸收的浓度给予PLO,对作为鼻黏膜损伤指标的乳酸脱氢酶活性和鼻液中的蛋白质渗漏没有影响。这些发现表明,使用PLO的经鼻给药系统是一种改善水溶性大分子鼻吸收且对鼻黏膜无毒性的有用策略。